[HTML][HTML] Standardized definitions for efficacy end points in neoadjuvant breast cancer clinical trials: NeoSTEEP
PURPOSE The Standardized Definitions for Efficacy End Points (STEEP) criteria,
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
JK Litton, MM Regan, L Pusztai… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose The Standardized Definitions for Efficacy End Points (STEEP) criteria, established
in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of adjuvant …
in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of adjuvant …
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
JK Litton, MM Regan, L Pusztai, HS Rugo… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE The Standardized Definitions for Efficacy End Points (STEEP) criteria,
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
JK Litton, MM Regan, L Pusztai… - Journal of …, 2023 - mdanderson.elsevierpure.com
Abstract PURPOSEThe Standardized Definitions for Efficacy End Points (STEEP) criteria,
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
S Tolaney, E Garrett-Mayer… - Journal of Clinical …, 2023 - escholarship.org
PURPOSE: The Standardized Definitions for Efficacy End Points (STEEP) criteria,
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
JK Litton, MM Regan, L Pusztai, HS Rugo… - Journal of Clinical …, 2023 - europepmc.org
Purpose The Standardized Definitions for Efficacy End Points (STEEP) criteria, established
in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of adjuvant …
in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of adjuvant …
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
JK Litton, MM Regan, L Pusztai… - Journal of Clinical …, 2023 - pure.johnshopkins.edu
Abstract PURPOSEThe Standardized Definitions for Efficacy End Points (STEEP) criteria,
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
JK Litton, MM Regan, L Pusztai… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE The Standardized Definitions for Efficacy End Points (STEEP) criteria,
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of …
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
JK Litton, MM Regan, L Pusztai, HS Rugo… - Journal of Clinical …, 2023 - europepmc.org
The Standardized Definitions for Efficacy End Points (STEEP) criteria, established in 2007
and updated in 2021 (STEEP 2.0), provide standardized definitions of adjuvant breast …
and updated in 2021 (STEEP 2.0), provide standardized definitions of adjuvant breast …